iBio
IBIO
#10059
Rank
A$0.10 B
Marketcap
A$1.69
Share price
0.85%
Change (1 day)
32.33%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.07. In 2025 the company made an earnings per share (EPS) of A-$2.50 an increase over its 2024 EPS that were of A-$9.30.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-53.19%
2025A-$2.50-73.08%
2024A-$9.30-93.88%
2023A-$151.98-8.14%
2022A-$165.4592.67%
2021A-$85.87-80.33%
2020A-$436.52-35.11%
2019A-$672.66-38.96%
2018A-$1,102-6.1%
2017A-$1,17436.67%
2016A-$858.7233.33%
2015A-$644.0450%
2014A-$429.36-53.85%
2013A-$930.28-7.14%
2012A-$1,002-64.1%
2011A-$2,79177.27%
2010A-$1,574144.44%
2009A-$644.0412.93%
2008A-$570.3112.2%
2007A-$508.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.50-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.74-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.59 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.92 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA